Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12688/f1000research.26084.1 http://scihub22266oqcxt.onion/10.12688/f1000research.26084.1 33145011!7590891!33145011     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33145011&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       F1000Res 2020 ; 9 (ä): 1043 Nephropedia Template TP {{tp|p=33145011|t=2020. Open science approaches to COVID-19 |pdf=|usr=}}{{33145011}} gab.com Text Open science approaches to COVID-19 JO: F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=33145011 #FOAvip In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded? Twit Text FOAVip Open science approaches to COVID-19 ????F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=33145011 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33145011 #FOAvip English Wikipedia <ref>{{Cite pmid|33145011}}</ref> Open science approaches to COVID-19 #MMPMID33145011 Tse EG; Klug DM; Todd MH F1000Res 2020[]; 9 (ä): 1043 PMID33145011show ga In only a matter of months, the coronavirus disease of 2019 (COVID-19) has spread around the world. The global impact of the disease has caused significant and repeated calls for quick action towards new medicines and vaccines. In response, researchers have adopted open science methods to begin to combat this disease via global collaborative efforts. We summarise here some of those initiatives, and have created an updateable list to which others may be added. Though open science has previously been shown as an accelerator of biomedical research, the COVID-19 crisis has made openness seem the logical choice. Will openness persist in the discovery of new medicines, after the crisis has receded? |*Coronavirus Infections[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |Betacoronavirus[MESH] |Biomedical Research/*trends[MESH] |COVID-19[MESH] |Humans[MESH] |Information Dissemination/*methods[MESH] |Open Access Publishing/*trends[MESH]Open science approaches to COVID-19 (epmc).pdf DeepDyve Pubget Overpricing